Osmotica Pharmaceutical's internal R&D capabilities include formulation research and development, analytical development, bioanalytical development, clinical development, laser drilling technologies, technology transfer/scale-up, regulatory sciences, Dossier submission management, and project management.
Expanded Use Policy
Osmotica Pharmaceutical US LLC does not currently provide unapproved medicines through expanded use programs. Clinical development is vitally important to Osmotica in order to provide innovative treatments to patients in need. The only way for patients to access investigational therapies in development by Osmotica is through participation in clinical trials submitted to the US Food and Drug Administration (FDA) or other regulatory authorities. Clinical trials are designed in an effort to gain knowledge into the safety and effectiveness of new medicinal treatments; additional information on available trials is posted at www.clinicaltrials.gov.